{
  "id": "0c2b6ddbf0c362d8",
  "title": "Eye Care-Focused Biopharma Firm SpyGlass Files for US IPO",
  "description": "SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such as glaucoma.",
  "content": "SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such as glaucoma.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-01-16/eye-care-focused-biopharma-firm-spyglass-files-for-us-ipo",
  "published_at": "2026-01-16T21:17:40+00:00",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "ipo",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Eye Care-Focused Biopharma Firm SpyGlass Files for US IPO",
    "description": "SpyGlass Pharma Inc. filed for an initial public offering to help fund late-stage trials of its intraocular lens and drug delivery solutions to treat patients with chronic eye conditions such as glaucoma.",
    "url": "https://www.bloomberg.com/news/articles/2026-01-16/eye-care-focused-biopharma-firm-spyglass-files-for-us-ipo",
    "published": "2026-01-16T21:17:40+00:00",
    "source": "Bloomberg Markets"
  }
}